Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Diabetes Care|April 27, 2022
Low-Dose Dasiglucagon Versus Oral Glucose for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes: A Phase 2, Randomized, Three-Arm Crossover StudyChristian Laugesen, Ajenthen G Ranjan, Signe Schmidt, et al.
Diabetologia|April 10, 2023
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trialChristian Laugesen, Ajenthen G Ranjan, Signe Schmidt, et al.
Sensors (Basel, Switzerland)|November 25, 2023
Factory-Calibrated Continuous Glucose Monitoring Systems in Type 1 Diabetes: Accuracy during In-Clinic Exercise and Home UseSissel Banner Lundemose, Christian Laugesen, Ajenthen Gayathri Ranjan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 23, 2025
Exploring low-dose glucagon for exercise-induced hypoglycaemia in type 1 diabetes: A randomised controlled trialSissel Banner Lundemose, Christian Laugesen, Ajenthen Gayathri Ranjan, et al.
Diabetes Technology & Therapeutics|September 28, 2019
Glucose Sensor Accuracy After Subcutaneous Glucagon Injections Near to Sensor SiteChristian Laugesen, Signe Schmidt, Rikke Tetzschner, et al.
Diabetes, Obesity & Metabolism|December 18, 2020
The effect of preceding glucose decline rate on low-dose glucagon efficacy in individuals with type 1 diabetes: A randomized crossover trialChristian Laugesen, Signe Schmidt, Jens Juul Holst, et al.
Diabetes Technology & Therapeutics|July 25, 2024
Frequency of Rebound Hyperglycemia in Adults with Type 1 Diabetes Treated with Different Insulin Delivery ModalitiesKatrine Grønbæk Tidemand, Christian Laugesen, Ajenthen Gayathri Ranjan, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 4, 2024
Pharmacokinetic/Pharmacodynamic Modeling of Efficacy and Hypoglycemia Rate When Switching From Once-Daily Basal Insulin to Once-Weekly Insulin Icodec Without or With a One-Time Additional Dose in Insulin-Experienced Individuals With Type 2 DiabetesIldiko Lingvay, Björg Ásbjörnsdóttir, Niels R Kristensen, et al.
Diabetes, Obesity & Metabolism|February 10, 2025
Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant-level analysis of the ONWARDS 1-5 trialsPeter Rossing, Malik Benamar, Alice Y Y Cheng, et al.
BMJ Open|November 16, 2020
Effect of adjunctive glucose-lowering drugs on body weight in people with type 1 diabetes: a systematic review and network meta-analysis protocolChristian Laugesen, Ajenthen G Ranjan, Signe Schmidt, et al.
Pageof 2